Extrafollicular responses in humans and SLE.

Area of Science:

• Immunology
• Autoimmunity
• B-cell Biology

Background:

• Chronic autoimmune diseases, such as Systemic Lupus Erythematosus (SLE), involve autoreactive B cells that periodically reactivate.
• Pathogenic autoantibodies in SLE often exhibit high somatic hypermutation and stability, suggesting T-cell-dependent germinal center (GC) reactions.
• However, B-cell extrafollicular (EF) reactions also generate pathogenic autoantibodies and are implicated in SLE flares.

Purpose of the Study:

• To review the characteristics of the EF B-cell pathway.
• To examine the relationship between EF B cells and other effector B-cell populations.
• To discuss the role of EF B cells in autoimmune diseases, particularly human SLE, and their connection to Age-Associated B cells (ABCs).

Main Methods:

• Literature review and synthesis of existing research on B-cell pathways in autoimmunity.
• Analysis of findings from mouse models and human studies in SLE.
• Discussion of the immunological properties and functions of EF B cells and ABCs.

Main Results:

• Human SLE flares show expansion of naive-derived activated effector B cells with an extrafollicular phenotype.
• EF B-cell reactions can generate pathogenic autoantibodies and contribute to autoimmune disease.
• Age-Associated B cells (ABCs), a TLR-7-driven population, are linked to EF B cells and mediate autoimmune responses.

Conclusions:

• The EF B-cell pathway is a significant contributor to pathogenic autoantibody generation and autoimmune disease pathogenesis in SLE.
• Understanding EF B cells and their relationship with ABCs offers insights into SLE mechanisms.
• Targeting EF B-cell pathways may represent a novel therapeutic strategy for SLE and other autoimmune conditions.